Benchmark Against the IP Community to Define & Implement a Robust Patent Strategy for Advanced Therapies to Minimize Risk & Ensure Exclusivity
Stay ahead in an era where advanced therapies are transforming medicine—and redefining how innovation must be protected. The IP & Patent Strategy for Advanced Therapies Summit 2025 is the only event dedicated to shaping holistic, forward-looking IP strategies exclusively for cell, gene, and next-generation treatments.
As more complex therapies move through development pipelines, traditional patent approaches fall short. This summit goes beyond technical tactics to tackle strategic decisions across the full patent life cycle, with a special emphasis on early-stage patentability, freedom to operate, and the use of AI-driven tools to uncover opportunity.
Against a backdrop of rapidly evolving regulations, patent cliffs, and landmark legal battles, now is the moment to rethink how you safeguard commercial potential and secure market advantage. Join top IP leaders to benchmark your approach and build the resilient strategy these therapies demand.
EXPLORE THE FULL EVENT GUIDE
- 60+ Senior IP leaders & legal experts
- 4 Specialized therapy areas covered
- 15+ In-depth sessions & panels on early-stage patentability, global filing strategies, and freedom to operate
- 6+ Hours of dedicated networking time
- 15+ Expert speakers from Regeneron, BioNTech, Beam Therapeutics, and more
World-Class Speaker Faculty Includes:
“Learning from other in-house counsel is so valuable, as we all deal with clients and outside counsel in a specific way. Meeting new people and building my network locally and beyond is priceless ”
In-House Impact: Biopharma Past Attendee
